Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 21, 2004 | May 14, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date May 21, 2004 · Filed May 14, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 19,700 |
Reported balance
After 2004-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2004-05-21 · Grant · Acquired 2,755 · Balance 19,700 F1: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2: Consists of Deferred Stock Compensation payable pursuant to Insider's election. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.53 · Expires 2005-01-11 | Direct | 2,310 |
Reported balance
Holding disclosure · report date 2004-05-21 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 2,310 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $29.93 · Expires 2012-01-02 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2004-05-21 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 15,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan.
F2: Consists of Deferred Stock Compensation payable pursuant to Insider's election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2004 Filed May 14, 2004 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,755 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000006 · c0001198221d20040514f4f.xml · derivative · entry 3 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,700 Underlying: Common Stock · 2,755 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| December 09, 2003 Filed Dec 9, 2003 22:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 110 | $34.74 | $3,821.40 |
DisclosureSEC source: 0001196361-03-000003 · c0001198221d20031209f4f.xml · nonDerivative · entry 3 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,915 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 09, 2003 Filed Dec 9, 2003 22:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,200 | $34.70 | $76,340.00 |
DisclosureSEC source: 0001196361-03-000003 · c0001198221d20031209f4f.xml · nonDerivative · entry 2 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,025 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 08, 2003 Filed Dec 9, 2003 22:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 2,310 | $0.00 Strike: $17.01 | $0.00 |
DisclosureSEC source: 0001196361-03-000003 · c0001198221d20031209f4f.xml · derivative · entry 5 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,310 shares Expires 2004-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Cash exercise funded by Insider. Read SEC document |
| December 08, 2003 Filed Dec 9, 2003 22:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 2,310 | $17.01 | $39,303.50 |
DisclosureSEC source: 0001196361-03-000003 · c0001198221d20031209f4f.xml · nonDerivative · entry 1 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 05, 2003 Filed Nov 7, 2003 14:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 284 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-03-000037 · c0001198221d20031107f4f.xml · derivative · entry 4 LAUTENBACH TERRY R · CIK 0001198221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,814 Underlying: Common Stock · 284 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.